|
|
||||||||
From the Autonomic Dysfunction Center, Vanderbilt University, Nashville, TN.
Address correspondence and reprint requests to Dr. Emily M. Garland, Autonomic Dysfunction Center, AA3228 Medical Center North, Vanderbilt University, 1161 21st Avenue South, Nashville, TN 37232-2195 emily.garland{at}vanderbilt.edu
Background: Previous studies of patients with postural tachycardia syndrome (POTS) have been hampered by relatively small cohorts, failure to control medications and diet, and inconsistent testing procedures.
Methods: The Vanderbilt Autonomic Dysfunction Center Database provided results of posture studies performed in 165 patients and 66 normal controls after dietary and medication restrictions. All posture studies were performed after an overnight fast and
30 minutes of supine rest.
Results: In both the supine and standing positions, heart rate (HR) and plasma concentrations of norepinephrine (NE), epinephrine, and dopamine were higher in patients with POTS compared with the healthy controls. Supine diastolic blood pressure (BP) was also elevated in POTS, whereas supine plasma l-3,4-dihydroxyphenyalanine was reduced. In an analysis of patient subgroups with either an upright plasma NE
3.54 nM (high NE) or an upright plasma NE < 3.54 nM (normal NE), HR and BP were greater in the patient subgroup with high NE. In addition to these significant differences in hemodynamic and catechol measurements, we demonstrated that supine and standing plasma aldosterone and the aldosterone/renin ratio were decreased in patients with POTS. Plasma renin activity (PRA) tended to be higher in patients, and standing HR for those in the highest PRA quartile was significantly greater than for those in the lowest PRA quartile.
Conclusions: Our results from larger cohorts of patients and controls than previously studied confirm published findings and contribute additional evidence of sympathetic activation in postural tachycardia syndrome (POTS). Abnormalities in the renin–angiotensin–aldosterone system may also contribute to the POTS phenotype.
Supported in part by NIH grants MO1 RR00095, R01 HL071784, K23 RR020783, and PO1 HL56693.
Disclosure: The authors report no conflicts of interest.
Received December 5, 2006. Accepted in final form March 23, 2007.
This article has been cited by other articles:
![]() |
L. R.A. Olde Nordkamp, W. Wieling, A. H. Zwinderman, A. A.M. Wilde, and N. van Dijk Genetic aspects of vasovagal syncope: a systematic review of current evidence Europace, April 1, 2009; 11(4): 414 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Ramirez-Marrero, N. Charkoudian, E. C. Hart, D. Schroeder, L. Zhong, J. H. Eisenach, and M. J. Joyner Cardiovascular dynamics in healthy subjects with differing heart rate responses to tilt J Appl Physiol, November 1, 2008; 105(5): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein and C. Holmes Neuronal Source of Plasma Dopamine Clin. Chem., November 1, 2008; 54(11): 1864 - 1871. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |